Literature DB >> 23547248

Andalusian initiative for advanced therapies: fostering synergies.

Natividad Cuende.   

Abstract

Mesh：

Year:  2013        PMID： 23547248      PMCID： PMC3659837          DOI： 10.5966/sctm.2013-0051

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN： 2157-6564            Impact factor:   6.940


× No keyword cloud information.
  2 in total

1.  Clinical translation of stem cell therapies: a bridgeable gap.

Authors:  Natividad Cuende; Ander Izeta
Journal:  Cell Stem Cell       Date:  2010-06-04       Impact factor: 24.633

Review 2.  Concise review: bone marrow mononuclear cells for the treatment of ischemic syndromes: medicinal product or cell transplantation?

Authors:  Natividad Cuende; Laura Rico; Concha Herrera
Journal:  Stem Cells Transl Med       Date:  2012-05-03       Impact factor: 6.940
  2 in total
  3 in total

1.  Evaluation of the awareness of novel advanced therapies among family medicine residents in Spain.

Authors:  Miguel Sola; Carmen Sanchez-Quevedo; Miguel A Martin-Piedra; Victor Carriel; Ingrid Garzon; Jesus Chato-Astrain; Oscar-Dario Garcia-Garcia; Miguel Alaminos; Fernando Campos
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

2.  Compliance in Non-Clinical Development of Cell-, Gene-, and Tissue-Based Medicines: Good Practice for Better Therapies.

Authors:  Luis Lopez-Navas; Sílvia Torrents; Rosario Sánchez-Pernaute; Joaquim Vives
Journal:  Stem Cells Transl Med       Date:  2022-08-23       Impact factor: 7.655

3.  Successful development and clinical translation of a novel anterior lamellar artificial cornea.

Authors:  Laura Rico-Sánchez; Ingrid Garzón; Miguel González-Andrades; Antonio Ruíz-García; Miriam Punzano; Antonio Lizana-Moreno; Jose Ignacio Muñoz-Ávila; Maria Del Carmen Sánchez-Quevedo; Juliana Martínez-Atienza; Luis Lopez-Navas; Rosario Sanchez-Pernaute; Roke Iñaki Oruezabal; Santiago Medialdea; Maria Del Carmen Gonzalez-Gallardo; Gloria Carmona; Sara Sanbonmatsu-Gámez; Matías Perez; Pilar Jimenez; Natividad Cuende; Antonio Campos; Miguel Alaminos
Journal:  J Tissue Eng Regen Med       Date:  2019-10-25       Impact factor: 3.963
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.